Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression
Wenjing Su, Hyun Ho Han, Yan Wang, et al.
Cancer Cell (2019) Vol. 36, Iss. 2, pp. 139-155.e10
Open Access | Times Cited: 179

Showing 26-50 of 179 citing articles:

CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling
Tao Xie, Du-Jiang Fu, Zhimin Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 61
Small-molecule inhibitors targeting Polycomb repressive complex 1 RING domain
Shirish Shukla, Weijiang Ying, Felicia Gray, et al.
Nature Chemical Biology (2021) Vol. 17, Iss. 7, pp. 784-793
Open Access | Times Cited: 58
Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy
Elnaz Rouzbahani, Jamal Majidpoor, Sajad Najafi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113906-113906
Open Access | Times Cited: 46
Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis
Hyun Ho Han, Yan Wang, Josué Curto, et al.
Cell Reports (2022) Vol. 39, Iss. 1, pp. 110595-110595
Open Access | Times Cited: 44
LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer
Iván Pérez-Núñez, Catalina Rozalén, José Ángel Palomeque, et al.
Nature Cancer (2022) Vol. 3, Iss. 3, pp. 355-370
Open Access | Times Cited: 43
Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer
Chaping Cheng, Jinming Wang, Penghui Xu, et al.
Nature Cancer (2022) Vol. 3, Iss. 5, pp. 565-580
Closed Access | Times Cited: 42
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Arian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Cancer Research (2023) Vol. 83, Iss. 16, pp. 2763-2774
Open Access | Times Cited: 31
CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression
Huiqiang Cai, Bin Zhang, Johanne Ahrenfeldt, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
m6A modification promotes EMT and metastasis of castration-resistant prostate cancer by upregulating NFIB
Feng Shu, Hao Liu, Xiaohui Chen, et al.
Cancer Research (2024) Vol. 84, Iss. 12, pp. 1947-1962
Closed Access | Times Cited: 11
Epigenetic underpinnings of tumor-immune dynamics in prostate cancer immune suppression
Duminduni H. Angappulige, Nupam P. Mahajan, Kiran Mahajan
Trends in cancer (2024) Vol. 10, Iss. 4, pp. 369-381
Open Access | Times Cited: 10
Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119
Thomas Köhnke, Kevin A. Nuno, Catherine Alder, et al.
Blood Cancer Discovery (2024) Vol. 5, Iss. 3, pp. 202-223
Open Access | Times Cited: 10
Fatty Acid Oxidation Supports Lymph Node Metastasis of Cervical Cancer via Acetyl‐CoA‐Mediated Stemness
Yuan Li, Hongye Jiang, Yan Jia, et al.
Advanced Science (2024) Vol. 11, Iss. 21
Open Access | Times Cited: 10
Overexpression of Malat1 drives metastasis through inflammatory reprogramming of the tumor microenvironment
Elena Martínez‐Terroba, Leah Plasek, Ioannis Chiotakakos, et al.
Science Immunology (2024) Vol. 9, Iss. 96
Closed Access | Times Cited: 9
Development of PRC1 Inhibitors Employing Fragment-Based Approach and NMR-Guided Optimization
Yiwu Yao, Miranda L. Simes, Weijiang Ying, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Tracing the Evolution of Sex Hormones and Receptor‐Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to Disease
Dengxiong Li, Zhipeng Wang, Qingxin Yu, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Cancer Immunotherapy via Targeting Cancer Stem Cells Using Vaccine Nanodiscs
Alireza Hassani Najafabadi, Jing Zhang, Marisa Aikins, et al.
Nano Letters (2020) Vol. 20, Iss. 10, pp. 7783-7792
Open Access | Times Cited: 70
Clinical considerations for the management of androgen indifferent prostate cancer
Jacob E. Berchuck, Paul V. Viscuse, Himisha Beltran, et al.
Prostate Cancer and Prostatic Diseases (2021) Vol. 24, Iss. 3, pp. 623-637
Open Access | Times Cited: 50
Epithelial–Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics
Luiz Paulo Chaves, Camila Morais Melo, Fabiano Pinto Saggioro, et al.
Genes (2021) Vol. 12, Iss. 12, pp. 1900-1900
Open Access | Times Cited: 49
NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy
Yoshihiro Otani, Ji Young Yoo, Cole T. Lewis, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 7, pp. 1460-1473
Open Access | Times Cited: 38
Epigenetic regulation of chemokine ( CC ‐motif) ligand 2 in inflammatory diseases
Yingyi Chen, Siyan Liu, Lili Wu, et al.
Cell Proliferation (2023) Vol. 56, Iss. 7
Open Access | Times Cited: 20
Epithelial-to-Mesenchymal Transition-Related Markers in Prostate Cancer: From Bench to Bedside
Samantha Gogola, Michael Rejzer, Hisham F. Bahmad, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2309-2309
Open Access | Times Cited: 17
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer
Zifeng Wang, Scott L. Townley, Songqi Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Adverse clinical outcomes and immunosuppressive microenvironment of RHO-GTPase activation pattern in hepatocellular carcinoma
Qi Yang, Zewei Zhuo, Xinqi Qiu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Calpain 8 as a potential biomarker regulates the progression of pancreatic cancer via EMT and AKT/ERK pathway
Na Song, Kai Cui, Liqun Zeng, et al.
Journal of Proteomics (2024) Vol. 301, pp. 105182-105182
Closed Access | Times Cited: 7
Advances in and prospects of immunotherapy for prostate cancer
Deng Liu, Luofu Wang, Yanli Guo
Cancer Letters (2024) Vol. 601, pp. 217155-217155
Open Access | Times Cited: 6

Scroll to top